VCNXのチャート
VCNXの企業情報
| symbol | VCNx |
|---|---|
| 会社名 | Vaccinex Inc （バクシネックス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Major Pharmaceuticals |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 ワクチンエックス(Vaccinex Inc.)は標的生物療法の発見と開発に従事する臨床段階のバイオテクノロジー企業である。同社はがん、神経変性疾患、自己免疫疾患などの疾患の治療法の提供に注力する。同社は非小細胞性肺癌、NSCLC、骨肉腫、メラノーマおよびハンチントン病の治療用リード製品候補VX15/2503 (VX15)の開発に焦点を当てたSEMA4D抗体プラットフォームを提供する。同社はまた、哺乳動物ウイルスのワクシニアの表面上に高親和性、全長ヒトモノクローナル抗体のライブラリーを発現させるために使用されるヒト抗体発見プラットフォームであるActiveMAb抗体検出プラットフォームも提供する。同社の製品候補VX5は多発性硬化症、潜在的自己免疫疾患の治療向け前臨床開発にある。 バクシネックスは米国のバイオ医薬品企業。臨床段階で、がん、神経変性疾患、自己免疫疾患などのヒト治療用モノクロナ―ル抗体および他の生物学的療法の開発に従事する。同社はがんの免疫療法の臨床試験において抗体産物を有し、それは神経変性ハンチントン病の発症を予防または遅延させる効果がある。本社所在地はニューヨーク州ロチェスタ―。 Vaccinex, Inc. is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The Company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that prevents immune infiltration into tumors and triggers chronic inflammation in the brain. The Company additionally intends to leverage its proprietary drug discovery platform, ActivMAb®, to create opportunities for future pipeline expansion and strategic collaborations, particularly by exploiting its unique capability to select high value antibodies against important multi-pass membrane receptors including GPCR and ion channels. |
| 本社所在地 | 1895 Mount Hope Avenue Rochester NY 14620 USA |
| 代表者氏名 | ― |
| 代表者役職名 | ― |
| 電話番号 | +1 585-271-2700 |
| 設立年月日 | 36982 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2018年 |
| 従業員数 | 44人 |
| url | www.vaccinex.com |
| nasdaq_url | https://www.nasdaq.com/symbol/vcnx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -23.57500 |
| 終値（lastsale） | 6.96 |
| 時価総額（marketcap） | 79871213.04 |
| 時価総額 | 時価総額（百万ドル） 75.16730 |
| 売上高 | 売上高（百万ドル） 0.42200 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 194.54830 |
| 当期純利益 | 当期純利益（百万ドル） -25.80700 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Vaccinex Inc revenues increased from $0K to $332K. Net loss applicable to common stockholders increased 32% to $16.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and developme increase of 38% to $9.9M (expense) G/L on early Exting of lease relat debt increase from $0K to $2.2M (expense). |
VCNXのテクニカル分析
VCNXのニュース
Can you now get a good deal on Vaccinex Inc.’s shares? 2023/02/20 15:24:00 US Post News
A share of Vaccinex Inc. (NASDAQ:VCNX) closed at $0.51 per share on Friday, down from $0.52 day before. While Vaccinex Inc. has underperformed by -1.36%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCNX fell by -68.83%, with highs and lows ranging from $1.70 to $0.41, […]
Teetering stocks: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR -3.97%), Vaccinex, Inc. (NASDAQ:VCNX -10.18%) 2023/02/13 12:07:26 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Teetering stocks: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR -3.97%), Vaccinex, Inc. (NASDAQ:VCNX -10.18%) appeared first on Stocks Equity .
Morning Stocks on the Move: Shift Technologies, Inc. (NASDAQ:SFT 2.38%), Vaccinex, Inc. (NASDAQ:VCNX -0.32%) 2023/02/09 18:02:18 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks on the Move: Shift Technologies, Inc. (NASDAQ:SFT 2.38%), Vaccinex, Inc. (NASDAQ:VCNX -0.32%) appeared first on Stocks Equity .
Morning Sizzling Stocks Alert: Vaccinex, Inc. (NASDAQ:VCNX -7.83%), Haleon plc (NYSE:HLN -0.86%) 2023/02/08 17:43:03 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Sizzling Stocks Alert: Vaccinex, Inc. (NASDAQ:VCNX -7.83%), Haleon plc (NYSE:HLN -0.86%) appeared first on Stocks Equity .
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday 2023/02/08 12:24:25 InvestorPlace
Source: f11photo/Shutterstock.com Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday! Moving stocks this morning are earnings reports, public offerings, and more AI news. Let’s get into that news at the links below! Pre-Market Stock Movers: 10 Top Gainers PainReform (NASDAQ: PRFX ) stock is rocketing more than 57% after getting an extension on its delisting . Aurora Mobile (NASDAQ: JG ) shares are soaring over 32% after revealing plans to add ChatGPT to its SMS and email services . Youdao (NYSE: DAO ) stock is surging more than 22% on Wednesday morning. Lion Group Holding (NASDAQ: LGHL ) shares are rising over 21% as it also plans to add ChatGPT to its services . SenesTech (NASDAQ: SNES ) stock is increasing more than 20% as it experiences volatility this week following a product update . Manchester United (NYSE: MANU ) shares are gaining over 18% on reports of an impending takeover bid . AERWINS Technologies (NASDAQ: AWIN ) stock is climbing more than 17% this morning.
Can you now get a good deal on Vaccinex Inc.’s shares? 2023/02/20 15:24:00 US Post News
A share of Vaccinex Inc. (NASDAQ:VCNX) closed at $0.51 per share on Friday, down from $0.52 day before. While Vaccinex Inc. has underperformed by -1.36%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VCNX fell by -68.83%, with highs and lows ranging from $1.70 to $0.41, […]
Teetering stocks: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR -3.97%), Vaccinex, Inc. (NASDAQ:VCNX -10.18%) 2023/02/13 12:07:26 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Teetering stocks: Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR -3.97%), Vaccinex, Inc. (NASDAQ:VCNX -10.18%) appeared first on Stocks Equity .
Morning Stocks on the Move: Shift Technologies, Inc. (NASDAQ:SFT 2.38%), Vaccinex, Inc. (NASDAQ:VCNX -0.32%) 2023/02/09 18:02:18 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Stocks on the Move: Shift Technologies, Inc. (NASDAQ:SFT 2.38%), Vaccinex, Inc. (NASDAQ:VCNX -0.32%) appeared first on Stocks Equity .
Morning Sizzling Stocks Alert: Vaccinex, Inc. (NASDAQ:VCNX -7.83%), Haleon plc (NYSE:HLN -0.86%) 2023/02/08 17:43:03 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Morning Sizzling Stocks Alert: Vaccinex, Inc. (NASDAQ:VCNX -7.83%), Haleon plc (NYSE:HLN -0.86%) appeared first on Stocks Equity .
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday 2023/02/08 12:24:25 InvestorPlace
Source: f11photo/Shutterstock.com Our coverage starts today with a look at the biggest pre-market stock movers traders will want to keep an eye on Wednesday! Moving stocks this morning are earnings reports, public offerings, and more AI news. Let’s get into that news at the links below! Pre-Market Stock Movers: 10 Top Gainers PainReform (NASDAQ: PRFX ) stock is rocketing more than 57% after getting an extension on its delisting . Aurora Mobile (NASDAQ: JG ) shares are soaring over 32% after revealing plans to add ChatGPT to its SMS and email services . Youdao (NYSE: DAO ) stock is surging more than 22% on Wednesday morning. Lion Group Holding (NASDAQ: LGHL ) shares are rising over 21% as it also plans to add ChatGPT to its services . SenesTech (NASDAQ: SNES ) stock is increasing more than 20% as it experiences volatility this week following a product update . Manchester United (NYSE: MANU ) shares are gaining over 18% on reports of an impending takeover bid . AERWINS Technologies (NASDAQ: AWIN ) stock is climbing more than 17% this morning.
The Daily Biotech Pulse: Eton Snags Second FDA Nod For Month, Vaccine Updates from Moderna, CureVac 2020/09/30 11:45:51 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc (NASDAQ: XLRN ) (announced Health Canada approval of luspatercept for RBC transfusion-dependent anemia associated with beta-thalassemia) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Adial Pharmaceuticals Inc (NASDAQ: ADIL )(announced EUA for antibody test for COVID-19) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Fate Therapeutics Inc (NASDAQ: FATE ) Guardant Health Inc (NASDAQ: GH ) Inspire Medical Systems Inc (NYSE: INSP ) Insulet Corporation (NASDAQ: PODD ) Kaleido Biosciences Inc (NASDAQ: KLDO )(announced dosing of first patient in ulcerative colitis study) Kura Oncology Inc (NASDAQ: KURA ) Lantern Pharma Inc.
The Week Ahead In Biotech: FDA Decisions For Mesoblast And Eton, Coronavirus Vaccine Updates 2020/09/26 18:40:57 Benzinga
Biotech stock reversed course last week, dragged lower by the broader market weakness. The week's news flow was headlined by Johnson & Johnson (NYSE: JNJ ) kickstarting a Phase 3 trial of its coronavirus vaccine candidate. A few clinical readouts released during the week triggered strong moves. Vaccinex Inc (NASDAQ: VCNX ) and AC Immune SA (NASDAQ: ACIU ) were among the worst decliners of the week, with the former reacting to a failed mid-stage trial of lead drug in Huntington's disease, while the latter plunged after an out-licensed Alzheimer's drug flunked a mid-stage trial. Here are the key catalysts for the unfolding week. Conferences World Muscle Society, or WMS, 25: Virtual Congress: Sept. 28-Oct. 2 Annual Northeast Amyotrophic Lateral Sclerosis, or NEALS, meeting: Sept. 30- Oct. 1 Heart Failure Society of America, or HFSA, Virtual Annual Scientific Meeting 2020: Sept. 30-Oct. 6 virtual Jefferies Cell Therapy Summit: Oct. 5-6 Virtual Jefferies Gene Therapy/Editing Summit: Oct. 1-2 North American Neuroendocrine Tumor Society, or NANETS', Multidisciplinary NET Medical Virtual Symposium: Oct.
Vaccinex Plummets After Lead Drug Flunks Midstage Huntingon's Disease Study 2020/09/22 11:20:00 Benzinga
Shares of micro-cap immunotherapy company Vaccinex Inc (NASDAQ: VCNX) were plunging Tuesday in reaction to an adverse readout. What Happened: Top-line …
Thinking about buying stock in Barnes & Noble Education, Vaccinex Inc, Seelos Therapeutics, PDS Biotechnology, or SINTX Technologies? 2020/07/17 13:31:00 PR Newswire
NEW YORK, July 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNED, VCNX, SEEL, PDSB, and SINT. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link….